Evaluating imaging methods for lymph node staging in breast cancer patients
Evaluation of Different Imaging Modalities in Regional Nodes Staging in Breast Cancer Patient
This study is testing different imaging methods to see which one best helps doctors find out if breast cancer has spread to nearby lymph nodes in patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 25 Years to 65 Years |
| Sex | Female |
| Sponsor | Sohag University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06185946 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of various imaging modalities in determining the status of regional lymph nodes in patients diagnosed with breast cancer. It will collect data from medical records, including patient demographics, family history, and imaging results, to evaluate the presence of tumor infiltration in lymph nodes. The imaging techniques used will include MRI, CT, mammography, and ultrasound, with interpretations provided by radiologists. The findings will help inform individualized treatment options based on lymph node involvement.
Who should consider this trial
Good fit: Ideal candidates for this study are breast cancer patients undergoing initial assessment who can tolerate various imaging modalities.
Not a fit: Patients who are unable to consent or are not fit for imaging evaluations due to health constraints will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate staging of lymph node involvement in breast cancer, allowing for tailored treatment plans.
How similar studies have performed: Previous studies have shown promising results in using imaging modalities for lymph node evaluation in breast cancer, suggesting that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient consenting to participate in the study. 2. Patients who can tolerate the imaging modalities and have proven to tolerate the contrast agents . 3) Breast cancer patients coming for an initial assessment with or without clinical regional lymph nodes positive status. 4) Breast cancer patients planned to have(breast-conserving surgery or mastectomy)as well as lymph node surgeries(sentinel lymph node v biopsy and/or axillary lymph node dissection. Exclusion Criteria: 1)Patients denying consent to participate in the study 2) Patients who are not fit for further imaging evaluation (patients who exceed the weight limit, patients who are sensitive to contrast material, etc). 3) Patients with bilateral MRM and AC -
Where this trial is running
Cairo
- National Cancer Institute — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Mennatallahh A Taha, assistant lecturer
- Email: menahallah.taha@med.sohag.edu.eg
- Phone: 00201005074579
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.